Paper11470906
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
Cravatt BF and 6 others. Proc Natl Acad Sci U S A, 2001. Cited by 1,069 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Papers, record 11470906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11470906
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amidohydrolases | Major topic |
| Arachidonic Acids | Major topic |
| Behavior, Animal | Major topic |
| Cannabinoids | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Brain | |
| Endocannabinoids | |
| Ethanolamines | |
| Mice | |
| Mice, Knockout | |
| Pain Threshold | |
| Polyunsaturated Alkamides | |
| Receptors, Cannabinoid | |
| Receptors, Drug | |
| Fatty Acid Amide Hydrolases |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DA 03672 | NIDA NIH HHS | United States | R01DA003672 | PubMed and NIH | NIH RePORTER |
| R01 DA013173 | NIDA NIH HHS | United States | R01DA013173 | PubMed and NIH | NIH RePORTER |
| DA 09789 | NIDA NIH HHS | United States | P01DA009789 | PubMed and NIH | NIH RePORTER |
| DA 131173 | NIDA NIH HHS | United States | PubMed | PubMed | |
| R01 MH058542 | NIMH NIH HHS | United States | R01MH058542 | PubMed and NIH | NIH RePORTER |
| MH 58542 | NIMH NIH HHS | United States | R01MH058542 | PubMed and NIH | NIH RePORTER |
| R37DA003672 | NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,470,919 | Isolation and structure of a brain constituent that binds to the cannabinoid receptor. | Science | 1992 | https://conductscience.org/library/papers/1470919 | PubMed |
| 2 | 9,685,157 | Control of pain initiation by endogenous cannabinoids. | Nature | 1998 | https://conductscience.org/library/papers/9685157 | PubMed |
| 3 | 8,395,053 | Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8395053 | PubMed |
| 4 | 8,373,432 | Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. | Biochem Pharmacol | 1993 | https://conductscience.org/library/papers/8373432 | PubMed |
| 5 | 7,906,042 | Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | Pharmacol Biochem Behav | 1993 | https://conductscience.org/library/papers/7906042 | PubMed |
| 6 | 8,129,747 | Effects of anandamide on cannabinoid receptors in rat brain membranes. | Biochem Pharmacol | 1994 | https://conductscience.org/library/papers/8129747 | PubMed |
| 7 | 9,790,682 | Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. | Biochemistry | 1998 | https://conductscience.org/library/papers/9790682 | PubMed |
| 8 | 9,842,734 | A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. | Proc Biol Sci | 1998 | https://conductscience.org/library/papers/9842734 | PubMed |
| 9 | 10,214,976 | Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. | Neurosci Lett | 1998 | https://conductscience.org/library/papers/10214976 | PubMed |
| 10 | 10,419,842 | Cannabinoids, endogenous ligands and synthetic analogs. | Curr Opin Chem Biol | 1999 | https://conductscience.org/library/papers/10419842 | PubMed |
| 11 | 10,431,820 | An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. | FEBS Lett | 1999 | https://conductscience.org/library/papers/10431820 | PubMed |
| 12 | 10,433,686 | Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. | Biochemistry | 1999 | https://conductscience.org/library/papers/10433686 | PubMed |
| 13 | 10,440,374 | Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. | Nature | 1999 | https://conductscience.org/library/papers/10440374 | PubMed |
| 14 | 10,462,059 | Discovery and characterization of endogenous cannabinoids. | Life Sci | 1999 | https://conductscience.org/library/papers/10462059 | PubMed |
| 15 | 10,518,599 | Pain modulation by release of the endogenous cannabinoid anandamide. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10518599 | PubMed |
| 16 | 10,570,211 | Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10570211 | PubMed |
| 17 | 10,780,247 | SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats. | Behav Pharmacol | 1999 | https://conductscience.org/library/papers/10780247 | PubMed |
| 18 | 10,805,767 | Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10805767 | PubMed |
| 19 | 10,838,609 | The endocannabinoid system as a target for therapeutic drugs. | Trends Pharmacol Sci | 2000 | https://conductscience.org/library/papers/10838609 | PubMed |
| 20 | 11,080,195 | Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. | J Neurochem | 2000 | https://conductscience.org/library/papers/11080195 | PubMed |
Cited by556
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,069 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,964,122 | MCH-02, a synthetic macamide analog with in vitro FAAH-inhibitory activity, modulates hippocampal endocannabinoid system and BK channel expression without preventing PTZ-induced progressive seizure susceptibility in rats. | Front Neurol | 2026 | https://conductscience.org/library/papers/42964122 | PubMed |
| 42,687,141 | N-Arachidonoyl-phosphatidylethanolamide phospholipase D activation by muscarinic receptors. | J Physiol | 2026 | https://conductscience.org/library/papers/42687141 | PubMed |
| 42,602,360 | Exercise-induced anandamide-CB1R signaling and prefrontal-amygdala stress circuits in adolescent depression: a critical hypothesis-driven narrative review. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42602360 | PubMed |
| 42,475,352 | Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model. | PLoS One | 2026 | https://conductscience.org/library/papers/42475352 | PubMed |
| 42,450,283 | Potential Molecular Associations Between Triphenyl Phosphate Exposure and Thyroid Cancer: Integration of Network Toxicology and Machine Learning for Core Target Identification with Molecular Docking. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450283 | PubMed |
| 42,314,784 | Sterol carrier protein 2 loss reduces anxiety and enhances fear extinction. | J Affect Disord | 2026 | https://conductscience.org/library/papers/42314784 | PubMed |
| 41,965,551 | Distribution and subacute modulation of endocannabinoid metabolizing enzymes in the trigeminal complex and midbrain in a pre-clinical model of post-traumatic headache. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41965551 | PubMed |
| 41,958,467 | Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population. | JGH Open | 2026 | https://conductscience.org/library/papers/41958467 | PubMed |
| 41,608,471 | The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41608471 | PubMed |
| 41,350,173 | FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/41350173 | PubMed |
| 41,310,892 | Characterization of cell-type specific knockout of different elements of the endocannabinoid system in cortical glutamatergic neurons in the context of stress-induced behavioral phenotype. | J Cannabis Res | 2025 | https://conductscience.org/library/papers/41310892 | PubMed |
| 40,943,321 | Anandamide Alters Glycolytic Activity in Streptococcus mutans: Metabolomics and Stable Isotope Labeling Study. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943321 | PubMed |
| 40,935,953 | Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. | Nat Rev Neurosci | 2025 | https://conductscience.org/library/papers/40935953 | PubMed |
| 40,924,628 | Acute Pain After Total Knee Arthroplasty: 2-Arachidonoylglycerol Tone and Endocannabinoid/Eicosanoid Crosstalk. | Anesth Analg | 2026 | https://conductscience.org/library/papers/40924628 | PubMed |
| 40,909,681 | The Contribution of Baseline Circulating Endocannabinoids to Individual Differences in Human Pain Sensitivity: A Quantitative Sensory Testing Study. | bioRxiv | 2025 | https://conductscience.org/library/papers/40909681 | PubMed |
| 40,860,020 | Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis. | HRB Open Res | 2025 | https://conductscience.org/library/papers/40860020 | PubMed |
| 40,835,854 | Personality-based intergenerational effects of prenatal THC exposure in an inherited mouse model of social dominance and submissiveness. | Sci Rep | 2025 | https://conductscience.org/library/papers/40835854 | PubMed |
| 40,799,255 | A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. | Drug Alcohol Depend Rep | 2025 | https://conductscience.org/library/papers/40799255 | PubMed |
| 40,797,173 | Substrate-selective COX-2 inhibition by IMMA attenuates posttraumatic headache via endocannabinoid modulation and neuroinflammatory suppression. | J Headache Pain | 2025 | https://conductscience.org/library/papers/40797173 | PubMed |
| 40,711,572 | Effects of acute alcohol administration on endocannabinoids and relation to subjective effects. | Psychopharmacology (Berl) | 2026 | https://conductscience.org/library/papers/40711572 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11470906
GET https://conductscience.org/api/papers/v1/11470906/references?page=2